|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Iobenguane
Market Report -- In Play (WIRES) - May 10, 2007 MSN MoneyMolecular Insight Pharmaceuticals (MIPI) announces that it has initiated a two-stage, Phase 1/2 therapeutic clinical trial for Azedra (Ultratrace iobenguane
AnazaoHealth Teddy Bears are 'Making It Bearable For Kids™' - Mar 22, 2007 SocialFunds.comMIBG (metaiodobenzylguanidine) is a biotracer that is combined with radioactive iodine to form either 123I-iobenguane metaiodobenzylguanidine, I-123 MIBG,
DRAXIS Posts Record Earnings and Cash Flow for 2006 - Feb 8, 2007 CNW Telbec (Communiqués de presse),In November 2006, DRAXIMAGE received approval from the US Food and Drug Administration (FDA) to run two clinical trials using radioactive Iobenguane I-131
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant ... - 18 Jan 2007 PipelineReview.com (press release),ZK-BA (Solazed(TM)) joins Azedra(TM) (Ultratrace(TM) iobenguane I 131) and Onalta(TM) (an yttrium-90 radiolabeled somatostatin peptide analog) in Molecular
DRAXIS Radiopharmaceutical Unit Approved To Run 2 Clinical Trials ... - Nov 23, 2006 Medical News Today (press release),...(TSX: DAX) (NASDAQ: DRAX) has been approved by the US Food and Drug Administration (FDA) to run two clinical trials using radioactive Iobenguane I-131 ...
DRAXIS Radiopharmaceutical Unit Approved to Run 2 Clinical Trials ... - Nov 22, 2006 CNW Telbec (Communiqués de presse),...(TSX: DAX) (NASDAQ: DRAX) has been approved by the US Food and Drug Administration (FDA) to run two clinical trials using radioactive Iobenguane I-131 ...
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|